The research aims to analyze the clinical and genetic aspects of acinar cell carcinoma (ACC) and its relationship to pancreatic ductal adenocarcinoma (PDAC).
Examined clinical data of acinar cell carcinoma cases
Analyzed genetic mutations, focusing on KRAS and TP53 pathways
Compared ACC features with those of pancreatic ductal adenocarcinoma
Identified significant mutations in KRAS and TP53 in ACC cases
Found distinctions between pure type ACC and mixed types
Noted the rarity of ACC, accounting for 1-2% of pancreatic cancers